参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/07 | 1,686 | 1,693 | 1,670 | 1,671 | +3 | +0.2% | 1,062,200 |
2021/01/06 | 1,648 | 1,681 | 1,647 | 1,668 | +17 | +1% | 744,300 |
2021/01/05 | 1,672 | 1,675 | 1,640 | 1,651 | -18 | -1.1% | 825,400 |
2021/01/04 | 1,680 | 1,682 | 1,652 | 1,669 | -6 | -0.4% | 502,300 |
2020/12/30 | 1,693 | 1,696 | 1,672 | 1,675 | -19 | -1.1% | 592,200 |
2020/12/29 | 1,665 | 1,699 | 1,658 | 1,694 | +41 | +2.5% | 853,200 |
2020/12/28 | 1,637 | 1,661 | 1,627 | 1,653 | +15 | +0.9% | 873,900 |
2020/12/25 | 1,647 | 1,651 | 1,633 | 1,638 | -14 | -0.8% | 483,100 |
2020/12/24 | 1,663 | 1,672 | 1,650 | 1,652 | -3 | -0.2% | 519,200 |
2020/12/23 | 1,675 | 1,677 | 1,647 | 1,655 | -1 | -0.1% | 1,017,100 |
2020/12/22 | 1,653 | 1,659 | 1,640 | 1,656 | -8 | -0.5% | 955,400 |
2020/12/21 | 1,686 | 1,689 | 1,646 | 1,664 | -17 | -1% | 1,084,100 |
2020/12/18 | 1,657 | 1,691 | 1,645 | 1,681 | +34 | +2.1% | 2,122,300 |
2020/12/17 | 1,672 | 1,673 | 1,631 | 1,647 | -24 | -1.4% | 1,654,900 |
2020/12/16 | 1,738 | 1,738 | 1,671 | 1,671 | -43 | -2.5% | 1,613,700 |
2020/12/15 | 1,720 | 1,727 | 1,708 | 1,714 | -3 | -0.2% | 1,091,500 |
2020/12/14 | 1,714 | 1,744 | 1,711 | 1,717 | +3 | +0.2% | 906,100 |
2020/12/11 | 1,708 | 1,723 | 1,692 | 1,714 | +6 | +0.4% | 722,600 |
2020/12/10 | 1,708 | 1,721 | 1,698 | 1,708 | -22 | -1.3% | 847,100 |
2020/12/09 | 1,712 | 1,732 | 1,710 | 1,730 | +27 | +1.6% | 1,031,100 |
2020/12/08 | 1,714 | 1,716 | 1,698 | 1,703 | -11 | -0.6% | 850,400 |
2020/12/07 | 1,724 | 1,732 | 1,713 | 1,714 | +19 | +1.1% | 1,007,100 |
2020/12/04 | 1,688 | 1,700 | 1,675 | 1,695 | +1 | +0.1% | 1,292,900 |
2020/12/03 | 1,702 | 1,711 | 1,690 | 1,694 | +1 | +0.1% | 1,132,300 |
2020/12/02 | 1,668 | 1,699 | 1,667 | 1,693 | +4 | +0.2% | 1,774,800 |
2020/12/01 | 1,735 | 1,737 | 1,669 | 1,689 | -46 | -2.7% | 2,474,800 |
2020/11/30 | 1,776 | 1,787 | 1,713 | 1,735 | -24 | -1.4% | 3,499,600 |
2020/11/27 | 1,739 | 1,770 | 1,734 | 1,759 | +26 | +1.5% | 1,929,900 |
2020/11/26 | 1,719 | 1,743 | 1,701 | 1,733 | +39 | +2.3% | 1,815,400 |
2020/11/25 | 1,714 | 1,728 | 1,690 | 1,694 | +3 | +0.2% | 1,830,300 |
2020/11/24 | 1,680 | 1,699 | 1,675 | 1,691 | +45 | +2.7% | 2,076,300 |
2020/11/20 | 1,650 | 1,665 | 1,638 | 1,646 | -10 | -0.6% | 1,301,500 |
2020/11/19 | 1,640 | 1,656 | 1,634 | 1,656 | +1 | +0.1% | 1,741,700 |
2020/11/18 | 1,655 | 1,666 | 1,629 | 1,655 | -36 | -2.1% | 2,493,900 |
2020/11/17 | 1,703 | 1,712 | 1,671 | 1,691 | -19 | -1.1% | 1,753,500 |
2020/11/16 | 1,701 | 1,723 | 1,697 | 1,710 | +13 | +0.8% | 1,219,700 |
2020/11/13 | 1,737 | 1,742 | 1,676 | 1,697 | -38 | -2.2% | 1,740,100 |
2020/11/12 | 1,751 | 1,776 | 1,728 | 1,735 | ±0 | ±0% | 2,247,700 |
2020/11/11 | 1,722 | 1,749 | 1,708 | 1,735 | +28 | +1.6% | 2,755,600 |
2020/11/10 | 1,765 | 1,778 | 1,700 | 1,707 | -57 | -3.2% | 2,866,200 |
2020/11/09 | 1,744 | 1,783 | 1,723 | 1,764 | -270 | -13.3% | 4,547,000 |
2020/11/06 | 2,022 | 2,052 | 1,999 | 2,034 | +18 | +0.9% | 1,274,900 |
2020/11/05 | 1,942 | 2,029 | 1,937 | 2,016 | +77 | +4% | 1,332,600 |
2020/11/04 | 1,909 | 1,946 | 1,884 | 1,939 | +42 | +2.2% | 934,100 |
2020/11/02 | 1,845 | 1,906 | 1,838 | 1,897 | +40 | +2.2% | 1,299,700 |
2020/10/30 | 1,935 | 1,935 | 1,850 | 1,857 | -81 | -4.2% | 1,185,300 |
2020/10/29 | 1,917 | 1,945 | 1,917 | 1,938 | ±0 | ±0% | 569,400 |
2020/10/28 | 1,930 | 1,943 | 1,919 | 1,938 | -10 | -0.5% | 552,700 |
2020/10/27 | 1,961 | 1,961 | 1,923 | 1,948 | -17 | -0.9% | 521,600 |
2020/10/26 | 1,982 | 1,999 | 1,960 | 1,965 | -25 | -1.3% | 362,600 |
951~
1000
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム